Linda Andersson

2.9k total citations
47 papers, 1.8k citations indexed

About

Linda Andersson is a scholar working on Molecular Biology, Biochemistry and Surgery. According to data from OpenAlex, Linda Andersson has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Biochemistry and 14 papers in Surgery. Recurrent topics in Linda Andersson's work include Lipid metabolism and biosynthesis (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Chemical Synthesis and Analysis (8 papers). Linda Andersson is often cited by papers focused on Lipid metabolism and biosynthesis (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Chemical Synthesis and Analysis (8 papers). Linda Andersson collaborates with scholars based in Sweden, Finland and United States. Linda Andersson's co-authors include Jan Borén, Sven‐Olof Olofsson, Mikael Rutberg, Pontus Boström, Jeanna Perman, Malin Levin, Johanna Ericson, Bengt R. Johansson, Martin Adiels and Michael A. Frohman and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Nature Cell Biology.

In The Last Decade

Linda Andersson

47 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda Andersson Sweden 21 776 775 419 366 349 47 1.8k
Geetha M. Habib United States 17 1.3k 1.6× 568 0.7× 161 0.4× 179 0.5× 119 0.3× 30 2.0k
Shunlin Ren United States 28 1.1k 1.4× 223 0.3× 497 1.2× 1.1k 2.9× 167 0.5× 57 2.4k
Robert A. Egnatchik United States 14 790 1.0× 149 0.2× 484 1.2× 158 0.4× 215 0.6× 16 1.5k
Dean J. Danner United States 25 830 1.1× 577 0.7× 575 1.4× 170 0.5× 334 1.0× 67 2.5k
Matthew A. Mitsche United States 18 920 1.2× 209 0.3× 244 0.6× 315 0.9× 96 0.3× 22 1.6k
Xing Gao China 22 797 1.0× 277 0.4× 186 0.4× 105 0.3× 196 0.6× 64 1.4k
Benjamin M. Buehrer United States 22 1.1k 1.4× 78 0.1× 315 0.8× 177 0.5× 308 0.9× 32 1.8k
Daisy Sahoo United States 21 633 0.8× 97 0.1× 161 0.4× 465 1.3× 92 0.3× 47 1.4k
Hong‐Hua Miao China 13 517 0.7× 116 0.1× 120 0.3× 486 1.3× 209 0.6× 20 1.1k
Kojiro Matsumoto Japan 27 1.3k 1.6× 83 0.1× 448 1.1× 129 0.4× 182 0.5× 81 2.1k

Countries citing papers authored by Linda Andersson

Since Specialization
Citations

This map shows the geographic impact of Linda Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Andersson more than expected).

Fields of papers citing papers by Linda Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Andersson. The network helps show where Linda Andersson may publish in the future.

Co-authorship network of co-authors of Linda Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Andersson. A scholar is included among the top collaborators of Linda Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Andersson. Linda Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Packard, C.J., Marja‐Riitta Taskinen, Elias Björnson, et al.. (2025). Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans. Atherosclerosis. 404. 119166–119166. 3 indexed citations
2.
Cinato, Mathieu, Linda Andersson, Marion Laudette, et al.. (2024). Role of Perilipins in Oxidative Stress—Implications for Cardiovascular Disease. Antioxidants. 13(2). 209–209. 18 indexed citations
3.
Taskinen, Marja‐Riitta, Niina Matikainen, Elias Björnson, et al.. (2023). Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy. Diabetologia. 66(12). 2307–2319. 11 indexed citations
4.
Cinato, Mathieu, Marion Laudette, Entela Bollano, et al.. (2023). Cardiac Plin5 interacts with SERCA2 and promotes calcium handling and cardiomyocyte contractility. Life Science Alliance. 6(4). e202201690–e202201690. 7 indexed citations
5.
Taskinen, Marja‐Riitta, Elias Björnson, Niina Matikainen, et al.. (2022). Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations. JCI Insight. 7(19). 22 indexed citations
6.
Taskinen, Marja‐Riitta, Elias Björnson, Juhani Kahri, et al.. (2020). Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes. Arteriosclerosis Thrombosis and Vascular Biology. 41(2). 962–975. 19 indexed citations
7.
Klevstig, Martina, Muhammad Arif, Maria Mannila, et al.. (2019). Cardiac expression of the microsomal triglyceride transport protein protects the heart function during ischemia. Journal of Molecular and Cellular Cardiology. 137. 1–8. 4 indexed citations
8.
Dalen, Knut Tomas, Marcus Ståhlman, Martina Klevstig, et al.. (2019). Plin2-deficiency reduces lipophagy and results in increased lipid accumulation in the heart. Scientific Reports. 9(1). 6909–6909. 41 indexed citations
9.
Taskinen, Marja‐Riitta, Elias Björnson, Linda Andersson, et al.. (2019). Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects. Journal of clinical lipidology. 14(1). 77–87. 24 indexed citations
10.
Andersson, Linda, Knut Tomas Dalen, Marcus Ståhlman, et al.. (2017). Deficiency in perilipin 5 reduces mitochondrial function and membrane depolarization in mouse hearts. The International Journal of Biochemistry & Cell Biology. 91. 9–13. 20 indexed citations
11.
Håversen, Liliana, Reza Mobini, Linda Andersson, et al.. (2016). ARAP2 promotes GLUT1-mediated basal glucose uptake through regulation of sphingolipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(11). 1643–1651. 13 indexed citations
12.
Klevstig, Martina, Marcus Ståhlman, Annika Lundqvist, et al.. (2016). Targeting acid sphingomyelinase reduces cardiac ceramide accumulation in the post-ischemic heart. Journal of Molecular and Cellular Cardiology. 93. 69–72. 42 indexed citations
13.
Andersson, Linda, Margareta Scharin Täng, Annika Lundqvist, et al.. (2015). Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia. Cardiovascular Research. 107(4). 478–486. 14 indexed citations
14.
Olofsson, Sven‐Olof, Linda Andersson, Liliana Håversen, et al.. (2011). The formation of lipid droplets: possible role in the development of insulin resistance/type 2 diabetes. Prostaglandins Leukotrienes and Essential Fatty Acids. 85(5). 215–218. 16 indexed citations
15.
Li, Lu, Pia Stillemark-Billton, Caroline B. Adiels, et al.. (2005). Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL. Journal of Lipid Research. 47(1). 67–77. 29 indexed citations
16.
Andersson, Linda, et al.. (2003). A surface exposed O-linked galactose residue destabilises the structure of a folded helix–loop–helix dimer. Organic & Biomolecular Chemistry. 1(14). 2455–2460. 7 indexed citations
17.
Marchesan, Denis, Mikael Rutberg, Linda Andersson, et al.. (2003). A Phospholipase D-dependent Process Forms Lipid Droplets Containing Caveolin, Adipocyte Differentiation-related Protein, and Vimentin in a Cell-free System. Journal of Biological Chemistry. 278(29). 27293–27300. 79 indexed citations
18.
19.
Ruoslahti, Erkki, Mikko Salaspuro, Helena Pihko, Linda Andersson, & Markku Seppälä. (1974). Serum α-Fetoprotein: Diagnostic Significance in Liver Disease. BMJ. 2(5918). 527–529. 86 indexed citations
20.
Andersson, Linda, et al.. (1973). Postoperative hypoparathyroidism. Hazards from vitamin D therapy.. PubMed. 139(5). 437–41. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geetha M. Habib Breakdown of academic impact, for papers by Shunlin Ren Breakdown of academic impact, for papers by Robert A. Egnatchik Breakdown of academic impact, for papers by Dean J. Danner Breakdown of academic impact, for papers by Matthew A. Mitsche Breakdown of academic impact, for papers by Xing Gao Breakdown of academic impact, for papers by Benjamin M. Buehrer Breakdown of academic impact, for papers by Daisy Sahoo Breakdown of academic impact, for papers by Hong‐Hua Miao Breakdown of academic impact, for papers by Kojiro Matsumoto
Rankless by CCL
2026